Blood
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma.
Sanjal H Desai, Alison J Moskowitz, Reid W Merryman, Harsh R Shah, Levi D Pederson, Susan Geyer, Nivetha Ganesan, Tiffany Chang, Tamer Othman, Ayo Samuel Falade, Gunjan L Shah, Urshila Durani, Nuttavut Sumransub, Lay She Ng, Kelsey Baron
Published: 202510.1182/blood.2025030151
Abstract
Combination therapy incorporating PD-1 blockade results in unprecedented response rates in both frontline and relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL). Prior retrospective studies have suggested benefit for PD-1 blockade pre-ASCT bu…
Preview only. Read the full abstract at the source